Showing results (71-80 of 345) with videos related to
Sort By:
Pageof 35
Clinical Case Reports|October 27, 2021
Guillain-Barré syndrome associated with inappropriate secretion of antidiuretic hormone following SARS-CoV-2 infection: A case-reportCarlo Santoro, Tommaso Guerra, Eustachio D'Errico, et al.International Journal of Molecular Sciences|November 23, 2018
Investigating the Role of MicroRNA and Transcription Factor Co-regulatory Networks in Multiple Sclerosis PathogenesisNicoletta Nuzziello, Laura Vilardo, Paride Pelucchi, et al.Neurologic Clinics|March 29, 2011
Natural history of multiple sclerosis: have available therapies impacted long-term prognosis?Maria Trojano, Damiano Paolicelli, Carla Tortorella, et al.Clinical Neurology and Neurosurgery|August 21, 2021
Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?Alessandro Introna, Francesca Caputo, Carlo Santoro, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 23, 2023
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)Clara G Chisari, Assunta Bianco, Vincenzo Brescia Morra, et al.Neurology|May 29, 2026
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term DisabilitySifat Sharmin, Izanne Roos, Pierre M Labauge, et al.European Journal of Neurology|July 3, 2021
First-line therapies in late-onset multiple sclerosis: An Italian registry studyAurora Zanghì, Carlo Avolio, Maria Pia Amato, et al.Cell Communication & Adhesion|May 15, 2003
Differential regulation of membrane bound and soluble ICAM 1 in human endothelium and blood mononuclear cells: effects of interferon beta-1aMaurizio Giorelli, Antonio De Blasi, Giovanni Defazio, et al.Antioxidants (Basel, Switzerland)|December 31, 2020
Mitochondria, Oxidative Stress, cAMP Signalling and Apoptosis: A Crossroads in Lymphocytes of Multiple Sclerosis, a Possible Role of NutraceuticsAnna Signorile, Anna Ferretta, Maddalena Ruggieri, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2025
Age-dependent response to initial highly effective treatment in relapsing multiple sclerosisEmilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.Pageof 35